Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 11 de 11
Filtrar
1.
Jt Comm J Qual Improv ; 27(11): 575-90, 2001 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-11708038

RESUMO

BACKGROUND: Several organizations have published evidence-based quality indicators for community-acquired pneumonia (CAP). However, there is variability in the types of indicators presented between organizations and the level of supporting evidence for each of the indicators. A systematic review of the literature and relevant Internet Web sites was performed to identify quality indicators for CAP that have been proposed or recommended by organizations, and each of the indicators was then critically appraised, using a well-defined set of criteria. METHODOLOGY: The MEDLINE, EMBASE, Best Evidence, and Cochrane Systematic Review databases and Internet Web sites were searched for articles and guidelines published between January 1980 and May 2001 to identify quality indicators for CAP and relevant evidence. Experts in the area of health services research were contacted to identify additional sources. A well-defined set of criteria was applied to evaluate each of the quality indicators. RESULTS: The systematic review of the literature and Internet Web sites yielded 44 CAP-specific quality indicators. The critical appraisal of these indicators yielded 16 indicators that were supported by a study that identified an association between quality of care and the process of care or outcome measure, were applied to enough patients to be able to detect clinically meaningful differences, were clinically and/or economically relevant, were measurable in a clinical practice setting, and were precise in their specifications. CONCLUSIONS: Many organizations recommend indicators for CAP. Indicators may serve as measures of clinical performance for clinicians and hospitals, may help in benchmarking, and may ultimately facilitate improvements in quality of care and cost reductions. However, CAP indicators often vary in their meaningfulness, scientific soundness, and interpretability of results. A set of five critical appraisal questions may assist in the evaluation of which quality indicators are most valid.


Assuntos
Influenza Humana/terapia , Pneumonia Pneumocócica/terapia , Pneumonia Viral/terapia , Indicadores de Qualidade em Assistência à Saúde , Infecções Comunitárias Adquiridas/prevenção & controle , Infecções Comunitárias Adquiridas/terapia , Medicina Baseada em Evidências , Humanos , Influenza Humana/prevenção & controle , Avaliação de Resultados em Cuidados de Saúde , Pneumonia Pneumocócica/prevenção & controle , Guias de Prática Clínica como Assunto , Qualidade da Assistência à Saúde
2.
Med Clin North Am ; 85(6): 1427-40, 2001 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-11686189

RESUMO

The rationale for achieving an early discharge for patients with CAP is that reduced length of stay can result in lower costs. When hospital discharge is premature, however, use of resources after discharge from the hospital may increase. This situation could increase overall cost and worsen quality of care. The objective should be to achieve a safe and early discharge. Several studies have evaluated methods for achieving this goal. Key findings from these studies are as follows: When a patient achieves clinical stability (e.g., systolic blood pressure, > or = 90 mm Hg; heart rate, < or = 100 beats/min; respiratory rate, < or = 24 breaths/min; temperature, < or = 38.3 degrees C [101 degrees F]; oxygen saturation, > or = 90%; able to eat; and stable mental status) or fulfills appropriate criteria (see Table 2), the patient may be eligible for switch from parenteral to oral antibiotics and early discharge. For many patients, this switch or discharge may occur on day 3 of hospitalization. When a patient is switched from parenteral to oral antibiotics, in many cases there does not appear to be a demonstrable clinical benefit to in-hospital observation. Elimination of in-hospital observation for patients who do not have an obvious reason for continued hospitalization potentially could reduce length of stay by 1 day. Improving efficiency of care reduces length of stay. This reduction may be accomplished by implementing clinical pathways, identifying and correcting causes of medically unnecessary hospital days, initiating early discharge planning, enlisting the services of a discharge coordinator, and organizing outpatient parenteral antibiotic treatment programs. These strategies are effective in many but not all patients, and their application should be tempered with careful clinical judgment.


Assuntos
Infecções Comunitárias Adquiridas/terapia , Tempo de Internação , Alta do Paciente/normas , Pneumonia/terapia , Fatores Etários , Idoso , Assistência Ambulatorial , Antibacterianos/uso terapêutico , Infecções Comunitárias Adquiridas/diagnóstico , Infecções Comunitárias Adquiridas/metabolismo , Procedimentos Clínicos/organização & administração , Eficiência Organizacional , Humanos , Tempo de Internação/economia , Tempo de Internação/estatística & dados numéricos , Avaliação de Processos e Resultados em Cuidados de Saúde/organização & administração , Alta do Paciente/economia , Alta do Paciente/estatística & dados numéricos , Seleção de Pacientes , Pneumonia/diagnóstico , Pneumonia/metabolismo , Qualidade da Assistência à Saúde , Segurança , Fatores de Tempo , Gestão da Qualidade Total/organização & administração , Resultado do Tratamento
4.
Arch Intern Med ; 161(5): 722-7, 2001 Mar 12.
Artigo em Inglês | MEDLINE | ID: mdl-11231705

RESUMO

BACKGROUND: The effectiveness of early switch and early discharge strategies in patients with community-acquired pneumonia remains unknown. METHODS: We searched the MEDLINE, HEALTHSTAR, EMBASE, Cochrane Collaboration, and Best Evidence databases from January 1, 1980, to March 31, 2000, for community-acquired pneumonia studies that included specific switch criteria or recommendations to switch on a particular day. RESULTS: From 1794 titles identified, 121 articles were reviewed. We identified 10 prospective, interventional, community-acquired pneumonia-specific studies that evaluated length of stay (LOS). Nine studies applied an early switch from parenteral to oral antibiotic criteria. Six different criteria for switching were applied in the 9 studies. Five of the studies that applied early switch criteria also applied separate criteria for early discharge. Six studies applied an early switch and early discharge strategy to an intervention and control group, and 5 of these provided SD values for LOS. The mean change in LOS was not significantly (P =.05) reduced in studies of early switch and early discharge (-1.64 days; 95% confidence interval, -3.30 to 0.02 days). However, when the 2 studies in which the recommended LOS was longer than the control LOS were excluded from the analysis, the mean change in LOS was reduced by 3 days (-3.04 days; 95% confidence interval, -4.90 to -1.19 days). Studies did not reveal significant differences in clinical outcomes between the intervention and control groups. CONCLUSIONS: There is considerable variability in early switch from parenteral to oral antibiotic criteria for patients with community-acquired pneumonia. Early switch and early discharge strategies may significantly and safely reduce the mean LOS when the recommended LOS is shorter than the actual LOS.


Assuntos
Antibacterianos/administração & dosagem , Pneumonia Bacteriana/tratamento farmacológico , Administração Oral , Antibacterianos/uso terapêutico , Distribuição de Qui-Quadrado , Protocolos Clínicos/normas , Infecções Comunitárias Adquiridas/tratamento farmacológico , Esquema de Medicação , Humanos , Infusões Intravenosas , Tempo de Internação/estatística & dados numéricos , Alta do Paciente/estatística & dados numéricos , Estudos Prospectivos
6.
J Gen Intern Med ; 14(6): 351-6, 1999 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-10354255

RESUMO

OBJECTIVE: To compare the effectiveness of three interventions designed to improve the pneumococcal vaccination rate. DESIGN: A prospective controlled trial. SETTING: Department of Veterans Affairs ambulatory care clinic. PATIENTS/PARTICIPANTS: There were 3, 502 outpatients with scheduled visits divided into three clinic teams (A, B, or C). INTERVENTIONS: During a 12-week period, each clinic team received one intervention: (A) nurse standing orders with comparative feedback as well as patient and clinician reminders; (B) nurse standing orders with compliance reminders as well as patient and clinician reminders; and (C) patient and clinician reminders alone. Team A nurses (comparative feedback group) received information on their vaccine rates relative to those of team B nurses. Team B nurses (compliance reminders group) received reminders to vaccinate but no information on vaccine rates. MEASUREMENTS AND MAIN RESULTS: Team A nurses assessed more patients than team B nurses (39% vs 34%, p =.009). However, vaccination rates per total patient population were similar (22% vs 25%, p =.09). The vaccination rates for both team A and team B were significantly higher than the 5% vaccination rate for team C (p <.001). CONCLUSIONS: Nurse-initiated vaccine protocols raised vaccination rates substantially more than a physician and patient reminder system. The nurse-initiated protocol with comparative feedback modestly improved the assessment rate compared with the protocol with compliance reminders, but overall vaccination rates were similar.


Assuntos
Vacinas Bacterianas/administração & dosagem , Protocolos Clínicos , Pneumonia Pneumocócica/prevenção & controle , Sistemas de Alerta , Vacinação/estatística & dados numéricos , Instituições de Assistência Ambulatorial , Análise Custo-Benefício , Seguimentos , Hospitais de Veteranos , Humanos , Enfermeiras e Enfermeiros , Vacinas Pneumocócicas , Estudos Prospectivos , Streptococcus pneumoniae , Estados Unidos
7.
JAMA ; 281(12): 1112-20, 1999.
Artigo em Inglês | MEDLINE | ID: mdl-10188663

RESUMO

OBJECTIVE: To establish, in a single resource, up-to-date recommendations for primary care physicians regarding prevention strategies for a first stroke. PARTICIPANTS: Members of the National Stroke Association's (NSA's) Stroke Prevention Advisory Board and Cedars-Sinai Health System Department of Health Services Research convened on April 9, 1998, in an open meeting. The conference attendees, selected to participate by the NSA, were recognized experts in neurology (9), cardiology (2), family practice (1), nursing (1), physician assistant practices (1), and health services research (2). EVIDENCE: A literature review was carried out by the Department of Health Services Research, Cedars-Sinai Health System, Los Angeles, Calif, using the MEDLINE database search for 1990 through April 1998 and updated in November 1998. English-language guidelines, statements, meta-analyses, and overviews on prevention of a first stroke were reviewed. CONSENSUS PROCESS: At the meeting, members of the advisory board identified 6 important stroke risk factors (hypertension, myocardial infarction [MI], atrial fibrillation, diabetes mellitus, blood lipids, asymptomatic carotid artery stenosis), and 4 lifestyle factors (cigarette smoking, alcohol use, physical activity, diet). CONCLUSIONS: Several interventions that modify well-documented and treatable cardiovascular and cerebrovascular risk factors can reduce the risk of a first stroke. Good evidence for direct stroke reduction exists for hypertension treatment; using warfarin for patients after MI who have atrial fibrillation, decreased left ventricular ejection fraction, or left ventricular thrombus; using 3-hydroxy-3 methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors for patients after MI; using warfarin for patients with atrial fibrillation and specific risk factors; and performing carotid endarterectomy for patients with stenosis of at least 60%. Observational studies support the role of modifying lifestyle-related risk factors (eg, smoking, alcohol use, physical activity, diet) in stroke prevention. Measures to help patients improve adherence are an important component of a stroke prevention plan.


Assuntos
Transtornos Cerebrovasculares/prevenção & controle , Guias de Prática Clínica como Assunto , Consumo de Bebidas Alcoólicas , Fibrilação Atrial/prevenção & controle , Doenças das Artérias Carótidas/prevenção & controle , Transtornos Cerebrovasculares/epidemiologia , Diabetes Mellitus/prevenção & controle , Exercício Físico , Humanos , Hipertensão/prevenção & controle , Estilo de Vida , Infarto do Miocárdio/prevenção & controle , Fatores de Risco
8.
Chest ; 114(1): 115-9, 1998 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-9674457

RESUMO

OBJECTIVE: To study the effect of a length of stay practice guideline on patient outcomes. DESIGN: A prospective, nonrandomized, interventional trial. SETTING: Six geographically distributed hospitals. PATIENTS: Two hundred forty-two consecutively hospitalized "low-risk" patients with pneumonia. MEASUREMENTS AND RESULTS: One hundred fifty-two patients (63%) completed the mailed postdischarge survey and were included in the analysis. Data were prospectively collected for 85 patients from the baseline observation period (B) and 67 patients from the intervention period (I). During the I, case managers provided physicians with patient risk information based on guideline recommendations. There was no significant change in guideline compliance (B vs I: 76.5% vs 83.6%; p=0.32) or length of stay (B vs I: 3.5 days [95% confidence interval, 3.2 to 3.8] vs 3.6 days [95% confidence interval, 3.3 to 4.0]). Also, there were no statistically significant effects of the intervention on patient outcomes, care following hospital discharge, and patient satisfaction scores. CONCLUSION: Patients in this study often had shorter lengths of stay than recommended by the practice guideline. This suggests that the external environment may have had a greater effect on physician behavior and length of stay than the practice guideline itself. Moreover, it demonstrates the importance of continuous assessment of physician practices immediately prior to, during, and after application of the clinical practice guideline.


Assuntos
Tempo de Internação , Pneumonia/tratamento farmacológico , Guias de Prática Clínica como Assunto , Atividades Cotidianas , Antibacterianos/administração & dosagem , Antibacterianos/uso terapêutico , Administração de Caso , Intervalos de Confiança , Feminino , Hospitalização , Humanos , Masculino , Auditoria Médica , Pessoa de Meia-Idade , Alta do Paciente , Readmissão do Paciente , Satisfação do Paciente , Pneumonia/enfermagem , Padrões de Prática Médica , Estudos Prospectivos , Qualidade de Vida , Fatores de Risco , Resultado do Tratamento
9.
Chest ; 113(1): 142-6, 1998 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-9440581

RESUMO

OBJECTIVE: To assess the benefit of in-hospital observation in "low-risk" patients with community-acquired pneumonia. DESIGN: Retrospective review of data from a prospective study. SETTING: Teaching community hospital. PATIENTS: We studied 717 consecutive, adult patients admitted to the hospital for pneumonia. MEASUREMENTS AND RESULTS: One hundred forty-five patients were classified at low-risk for complications using previously studied criteria; 144 (99%) charts were available for review. Two patients had "obvious reasons for continued hospitalization" on the day of antibiotic conversion and were excluded. One hundred two patients were observed, and 40 were not observed in-hospital after switch to oral antibiotics. No patient from either group required medical intervention within 24 h after hospital discharge. Five "observed" patients (5%, 95% confidence interval [CI], 2 to 11%) returned to the emergency department, three (3%; 95% CI, 0 to 9%) with respiratory complaints. Two (2%; 95% CI, 0 to 7%) "observed" patients were admitted to the hospital with recurrent pneumonia. One (3%; 95% CI, 0 to 13%) "not observed" patient returned to the emergency department with a nonrespiratory complaint and was not admitted. No patient from either group died within 30-day clinical follow-up. The length of stay for the "observed" and "not observed" groups was 98+/-33 h and 83+/-49 h, respectively. The difference in length of stay was 15 h (95% CI, 3 to 27). CONCLUSIONS: In-hospital observation for low-risk patients admitted with community-acquired pneumonia after switch from parenteral to oral antibiotics is of limited benefit, and elimination of this practice could potentially reduce length of stay by almost 1 day per patient. This could translate into a cost savings of $57,200 for the 22-month study period. These results require prospective validation in a larger study.


Assuntos
Antibacterianos/administração & dosagem , Infecções Comunitárias Adquiridas/tratamento farmacológico , Hospitalização , Pneumonia Bacteriana/tratamento farmacológico , Administração Oral , Adulto , Idoso , Idoso de 80 Anos ou mais , Antibacterianos/uso terapêutico , Infecções Comunitárias Adquiridas/economia , Custos e Análise de Custo , Feminino , Seguimentos , Pesquisa sobre Serviços de Saúde , Hospitalização/economia , Humanos , Infusões Parenterais , Tempo de Internação , Masculino , Pessoa de Meia-Idade , Pneumonia Bacteriana/economia , Estudos Prospectivos , Recidiva , Resultado do Tratamento
10.
Clin Infect Dis ; 21(4): 1014-6, 1995 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-8645790

RESUMO

Adult T-cell leukemia/lymphoma (ATLL) is caused by the human T-cell lymphotropic virus type I (HTLV-I). ATLL is classified into the smoldering, chronic, lymphoma, and acute subtypes. We describe a North American woman with chronic ATLL who presented with pneumonia caused by Pneumocystis carinii, Cryptococcus neoformans, Mycoplasma pneumoniae, and Mycobacterium avium complex. Although opportunistic infections have been documented in patients with ATLL, there are few case reports detailing infectious complications in patients with chronic ATLL.


Assuntos
Leucemia Prolinfocítica de Células T/virologia , Leucemia-Linfoma de Células T do Adulto/virologia , Infecções Oportunistas/microbiologia , Pneumonia Bacteriana/complicações , Idoso , Idoso de 80 Anos ou mais , Cryptococcus neoformans/isolamento & purificação , Evolução Fatal , Feminino , Vírus Linfotrópico T Tipo 1 Humano/isolamento & purificação , Humanos , Leucemia Prolinfocítica de Células T/complicações , Leucemia-Linfoma de Células T do Adulto/complicações , Complexo Mycobacterium avium/isolamento & purificação , Mycoplasma pneumoniae/isolamento & purificação , Pneumocystis/isolamento & purificação , Pneumonia Bacteriana/microbiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...